Xinpeng Fan
Lanzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Targeting PSMB5-induced PANoptosis in bladder cancer: multi-omics insights and TCM candidate discovery.
Journal: Frontiers in immunology
Published: June 30, 2025
Integrating analysis of multi-omics summary data identifies novel plasma protein biomarkers and drug targets for bladder cancer.
Journal: Discover oncology
Published: December 03, 2024
The MCM6-c-Myc positive feedback loop mediates bladder cancer progression and cisplatin resistance.
Journal: International journal of biological macromolecules
Published: October 21, 2024
Comment on: "Open versus robot‑assisted partial nephrectomy for highly complex renal masses: a meta‑analysis of perioperative and functional outcomes".
Journal: Journal of robotic surgery
Published: September 15, 2024
Transcription factor PRRX1-activated ANXA6 facilitates EGFR-PKCα complex formation and enhances cisplatin sensitivity in bladder cancer.
Journal: Life sciences
Published: July 10, 2024
Identification of the role of MCM6 in bladder cancer prognosis, immunotherapy response, and in vitro experimental investigation using multi-omics analysis.
Journal: Life sciences
Published: August 17, 2023
The predictive efficacy of tumor mutation burden in immunotherapy across multiple cancer types: A meta-analysis and bioinformatics analysis.
Journal: Translational oncology
Published: February 11, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026